(Q85047853)

English

Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis

scientific article published on 01 March 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

zoledronic acid

1 reference

based on heuristic

inferred from title

glucocorticoid-induced osteoporosis

1 reference

based on heuristic

inferred from title

author name string

C Roux

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

D M Reid

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J-P Devogelaer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

K Saag

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C S Lau

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J-Y Reginster

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

P Papanastasiou

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Bucci-Rechtweg

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G Su

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

P N Sambrook

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Osteoporosis International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1083-1090

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975559%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroid-induced osteoporosis: pathogenesis and prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of glucocorticoid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in vertebral fracture risk in postmenopausal women using omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroids and ulcers: is there an association?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of corticosteroid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RETRACTED: Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-resorptives in the management of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vertebral Fracture Risk With Long-term Corticosteroid Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of proton pump inhibitors and risk of osteoporosis-related fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoids and the risk of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zoledronic acid and clinical fractures and mortality after hip fracture

1 reference

https://pubmed.ncbi.nlm.nih.gov/21975559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85047853&oldid=2221704355"